Search research articles
Contact Us
Filters
Showing results (181-190 of 215) with videos related to
Page
of 22
Sort By:
Leukemia
|
August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
M Oosterveld, P Muus, S Suciu, et al.
Lancet (London, England)
|
May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation
F Frassoni, M Labopin, R Powles, et al.
Bone Marrow Transplantation
|
July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT
Y Chalandon, J R Passweg, C Schmid, et al.
British Journal of Haematology
|
September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
S Keating, T de Witte, S Suciu, et al.
Annals of Hematology
|
September 22, 2016
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
E M P Cremers, A van Biezen, L C de Wreede, et al.
Bone Marrow Transplantation
|
August 16, 2002
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
A Urbano-Ispizua, N Schmitz, T de Witte, et al.
Leukemia
|
October 1, 2010
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
M Robin, G F Sanz, I Ionescu, et al.
BMC Health Services Research
|
March 26, 2022
Identifying client characteristics to predict homecare use more accurately: a Delphi-study involving nurses and homecare purchasing specialists
Anne O E van den Bulck, Arianne M J Elissen, Silke F Metzelthin, et al.
Bone Marrow Transplantation
|
March 7, 1998
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
V Runde, T de Witte, R Arnold, et al.
British Journal of Haematology
|
September 21, 2000
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
T de Witte, J Hermans, J Vossen, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 215) with videos related to
Sort By:
Page
of 22
Leukemia
|
August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
M Oosterveld, P Muus, S Suciu, et al.
Lancet (London, England)
|
May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation
F Frassoni, M Labopin, R Powles, et al.
Bone Marrow Transplantation
|
July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT
Y Chalandon, J R Passweg, C Schmid, et al.
British Journal of Haematology
|
September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
S Keating, T de Witte, S Suciu, et al.
Annals of Hematology
|
September 22, 2016
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
E M P Cremers, A van Biezen, L C de Wreede, et al.
Bone Marrow Transplantation
|
August 16, 2002
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
A Urbano-Ispizua, N Schmitz, T de Witte, et al.
Leukemia
|
October 1, 2010
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
M Robin, G F Sanz, I Ionescu, et al.
BMC Health Services Research
|
March 26, 2022
Identifying client characteristics to predict homecare use more accurately: a Delphi-study involving nurses and homecare purchasing specialists
Anne O E van den Bulck, Arianne M J Elissen, Silke F Metzelthin, et al.
Bone Marrow Transplantation
|
March 7, 1998
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
V Runde, T de Witte, R Arnold, et al.
British Journal of Haematology
|
September 21, 2000
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
T de Witte, J Hermans, J Vossen, et al.
Page
of 22